Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile

Lepu Medical Technology Beijing Co Stock

300003.SZ
CNE100000H44

Price

13.40
Today +/-
+0
Today %
+0 %
P

Lepu Medical Technology Beijing Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lepu Medical Technology Beijing Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lepu Medical Technology Beijing Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lepu Medical Technology Beijing Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lepu Medical Technology Beijing Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lepu Medical Technology Beijing Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lepu Medical Technology Beijing Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lepu Medical Technology Beijing Co’s growth potential.

Lepu Medical Technology Beijing Co Revenue, EBIT and net profit per share

DateLepu Medical Technology Beijing Co RevenueLepu Medical Technology Beijing Co EBITLepu Medical Technology Beijing Co Net Income
2026e11.65 B undefined3.19 B undefined2.32 B undefined
2025e10.26 B undefined2.84 B undefined1.99 B undefined
2024e9.02 B undefined2.55 B undefined1.73 B undefined
20237.98 B undefined1.67 B undefined1.26 B undefined
202210.61 B undefined2.78 B undefined2.2 B undefined
202110.66 B undefined2.7 B undefined1.72 B undefined
20208.04 B undefined2.1 B undefined1.8 B undefined
20197.8 B undefined2.26 B undefined1.73 B undefined
20186.36 B undefined1.74 B undefined1.22 B undefined
20174.54 B undefined1.29 B undefined899.1 M undefined
20163.47 B undefined926.4 M undefined679.3 M undefined
20152.77 B undefined704 M undefined520.9 M undefined
20141.67 B undefined504.3 M undefined423.2 M undefined
20131.3 B undefined403.3 M undefined361.6 M undefined
20121.02 B undefined434.5 M undefined403.3 M undefined
2011919.8 M undefined505.7 M undefined473.2 M undefined
2010770.1 M undefined446.8 M undefined410.5 M undefined
2009565.2 M undefined320.9 M undefined292.2 M undefined
2008393.9 M undefined197.8 M undefined201.4 M undefined
2007299 M undefined144.7 M undefined149.7 M undefined
2006175.3 M undefined79.8 M undefined63.6 M undefined

Lepu Medical Technology Beijing Co Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
2006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.180.30.390.570.770.921.021.31.672.773.474.546.367.88.0410.6610.617.989.0210.2611.65
-70.8631.4443.7736.2819.3510.4528.3728.0165.9525.2530.8640.0922.643.1232.61-0.47-24.7913.0613.6813.59
69.7174.9278.6381.7782.6081.3977.9368.8463.4355.2060.8367.1872.6672.1566.9160.9262.1062.64---
0.120.220.310.460.640.750.790.91.061.532.113.054.625.625.386.496.595000
0.080.140.20.320.450.510.430.40.50.70.931.291.742.262.12.72.781.672.552.843.19
45.1448.1650.1356.6457.9254.9542.7630.9330.2225.4326.7128.4327.3928.9726.1325.3326.1920.9428.3127.7027.38
0.060.150.20.290.410.470.40.360.420.520.680.91.221.731.81.722.21.261.731.992.32
-136.5134.9045.2740.4115.37-14.80-10.4217.1722.9330.5832.4035.4841.634.41-4.5528.10-42.8737.3615.2816.32
---------------------
---------------------
0.491.211.461.51.621.621.621.621.621.621.741.781.781.771.781.811.821.86000
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Lepu Medical Technology Beijing Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Lepu Medical Technology Beijing Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Lepu Medical Technology Beijing Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Lepu Medical Technology Beijing Co's financial health and stability.

Assets

Lepu Medical Technology Beijing Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Lepu Medical Technology Beijing Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Lepu Medical Technology Beijing Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Lepu Medical Technology Beijing Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200620072008200920102011201220132014201520162017201820192020202120212022
0000000000000001.7202.2
0000000000000004480616
000000000000000-660-13
-40-33-59-84-104-128-339-409-501-833-1,173-1,726-2,622-3,323-3,444142-3,994-3,781
0000000000000006780375
000000000000000000
-22-55-59-113-163-199-228-226-267-343-462-665-942-984-831725-725-962
0.060.060.190.240.370.290.270.330.350.440.690.911.51.992.093.063.062.79
-38-20-122-93-146-132-101-99-126-164-123-716-1,071-563-600-984-984-905
-38-43-180-102-328-168-139-563-688-1,216-1,438-1,700-2,322-651-695-860-860-1,599
0-22-57-9-182-35-37-464-562-1,051-1,315-984-1,250-88-95123123-694
000000000000000000
0000.03-0.0300-0.020.240.981.121.412.6-0.54-0.1-0.59-0.51-0.69
000000000000000-0.1101.29
0.010.11-0.030.97-0.1-0.22-0.13-0.170.132.10.780.970.77-1.55-0.76-0.9-0.90.41
0.010.150.021.160.0100.01001.26-0.12-0.16-1.36-0.37-0.070.390.21.74
0-37-47-221-83-221-146-146-106-140-219-281-477-639-598-587-587-635
0.150.280.291.540.590.520.830.560.912.942.363.495.036.096.979.099.079.16
20.240.865.7146.5228158.3163.7230.8222.1271.8568.8197428.61,427.21,489.62,077.592,077.61,885.49
000000000000000000

Lepu Medical Technology Beijing Co stock margins

The Lepu Medical Technology Beijing Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lepu Medical Technology Beijing Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lepu Medical Technology Beijing Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lepu Medical Technology Beijing Co's sales revenue. A higher gross margin percentage indicates that the Lepu Medical Technology Beijing Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lepu Medical Technology Beijing Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lepu Medical Technology Beijing Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lepu Medical Technology Beijing Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lepu Medical Technology Beijing Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lepu Medical Technology Beijing Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lepu Medical Technology Beijing Co Margin History

Lepu Medical Technology Beijing Co Gross marginLepu Medical Technology Beijing Co Profit marginLepu Medical Technology Beijing Co EBIT marginLepu Medical Technology Beijing Co Profit margin
2026e62.63 %27.38 %19.89 %
2025e62.63 %27.7 %19.43 %
2024e62.63 %28.31 %19.16 %
202362.63 %20.95 %15.77 %
202262.1 %26.19 %20.76 %
202160.92 %25.33 %16.13 %
202066.9 %26.12 %22.42 %
201972.15 %28.98 %22.13 %
201872.66 %27.4 %19.17 %
201767.19 %28.43 %19.81 %
201660.82 %26.72 %19.59 %
201555.2 %25.43 %18.81 %
201463.43 %30.22 %25.36 %
201368.88 %30.94 %27.74 %
201277.91 %42.77 %39.7 %
201181.42 %54.98 %51.45 %
201082.61 %58.02 %53.3 %
200981.79 %56.78 %51.7 %
200878.52 %50.22 %51.13 %
200775.05 %48.39 %50.07 %
200669.94 %45.52 %36.28 %

Lepu Medical Technology Beijing Co Stock Sales Revenue, EBIT, Earnings per Share

The Lepu Medical Technology Beijing Co earnings per share therefore indicates how much revenue Lepu Medical Technology Beijing Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lepu Medical Technology Beijing Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lepu Medical Technology Beijing Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lepu Medical Technology Beijing Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lepu Medical Technology Beijing Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lepu Medical Technology Beijing Co Revenue, EBIT and net profit per share

DateLepu Medical Technology Beijing Co Sales per ShareLepu Medical Technology Beijing Co EBIT per shareLepu Medical Technology Beijing Co Earnings per Share
2026e7.31 undefined0 undefined1.45 undefined
2025e6.44 undefined0 undefined1.25 undefined
2024e5.66 undefined0 undefined1.08 undefined
20234.29 undefined0.9 undefined0.68 undefined
20225.84 undefined1.53 undefined1.21 undefined
20215.9 undefined1.49 undefined0.95 undefined
20204.52 undefined1.18 undefined1.01 undefined
20194.41 undefined1.28 undefined0.98 undefined
20183.57 undefined0.98 undefined0.68 undefined
20172.55 undefined0.72 undefined0.5 undefined
20162 undefined0.53 undefined0.39 undefined
20151.7 undefined0.43 undefined0.32 undefined
20141.03 undefined0.31 undefined0.26 undefined
20130.8 undefined0.25 undefined0.22 undefined
20120.63 undefined0.27 undefined0.25 undefined
20110.57 undefined0.31 undefined0.29 undefined
20100.47 undefined0.28 undefined0.25 undefined
20090.38 undefined0.21 undefined0.19 undefined
20080.27 undefined0.14 undefined0.14 undefined
20070.25 undefined0.12 undefined0.12 undefined
20060.36 undefined0.16 undefined0.13 undefined

Lepu Medical Technology Beijing Co business model

Lepu Medical Technology Beijing Co Ltd was founded in 1999 and is a China-based company specializing in medical devices. The company is headquartered in Beijing and has branches and partners in over 70 countries worldwide. Business Model Lepu Medical's business model is based on the development, production, and distribution of medical devices and consumables. The company is divided into various divisions operating in the field of medical technology, including Cardiovascular, Neurovascular, Structural Heart, Peripheral Vascular, Interventional Oncology, and Infection Control. Products Lepu's products include a wide range of medical devices and consumables for various medical fields. In the Cardiovascular field, the company offers stents, balloon catheters, guide catheters, and vascular closure devices for peripheral vessels, cardiac surgery, and interventional cardiology. In the Neurovascular field, the company provides devices for the treatment of strokes that can dissolve blood clots in the brain. In the Structural Heart field, the company offers pericardial closure systems for minimally invasive treatment of heart defects. The Peripheral Vascular field includes devices for the treatment of diseases in other vessels in the body, such as the legs. Interventional Oncology involves devices for the treatment of cancer through targeted injection of chemotherapy or radioisotopes directly into the tumor. The Infection Control division includes medical devices and consumables for preventing infections during surgical procedures. History Lepu Medical Technology Beijing Co Ltd was founded in 1999 as a distributor of medical devices and consumables. In subsequent years, Lepu developed its own medical devices, laying the foundation for the company's success. In 2009, the company went public on the Shenzhen Stock Exchange. In the same year, Lepu introduced its first newly developed product, a stent for the treatment of peripheral vascular disease, to the Chinese market. Since then, Lepu Medical Technology Beijing Co Ltd has driven continuous expansion through product optimization and strategic acquisitions. Conclusion Lepu Medical Technology Beijing Co Ltd has established itself in the market for medical devices and consumables through its innovative products and constant expansion. The company is divided into various divisions specializing in specific medical fields. The wide range of products offered by the company has made it a significant player in the international market. Lepu Medical Technology Beijing Co is one of the most popular companies on Eulerpool.com.

Lepu Medical Technology Beijing Co SWOT Analysis

Strengths

Lepu Medical Technology Beijing Co Ltd has several strengths that contribute to its competitive advantage in the market. These strengths include:

  • Advanced Technology: Lepu Medical Technology is known for its innovative and cutting-edge medical devices and technologies, which allow them to offer high-quality healthcare solutions to their customers.
  • Strong Research and Development (R&D) Capabilities: The company invests heavily in R&D to continuously improve its product offerings and stay ahead of the competition. This helps them meet the evolving needs of the healthcare industry.
  • Established Brand Image: Lepu Medical Technology has built a strong brand reputation and has gained the trust of healthcare professionals and consumers.
  • Wide Product Portfolio: The company offers a diverse range of medical devices and equipment, providing them with a competitive edge in serving different segments of the healthcare market.

Weaknesses

Despite its strengths, Lepu Medical Technology also faces certain weaknesses, which may potentially hinder its growth and market competitiveness. These weaknesses include:

  • Dependence on China Market: Lepu Medical Technology heavily relies on the Chinese market for its revenue, which exposes them to risks associated with changes in government policies, economic conditions, and other market factors.
  • Limited Global Presence: Although Lepu Medical Technology has made efforts to expand globally, they still have a relatively smaller international footprint compared to some of their competitors. This limits their market reach and potential growth in certain regions.
  • Increased Competition: The medical technology industry is highly competitive, with numerous local and international players vying for market share. Lepu Medical Technology needs to consistently differentiate itself and offer unique value propositions to stay ahead in the market.

Opportunities

There are several opportunities that Lepu Medical Technology can leverage to further strengthen its market position and drive growth. These opportunities include:

  • Growing Demand for Medical Devices: The increasing prevalence of chronic diseases and the aging population worldwide have created a growing demand for advanced medical devices. Lepu Medical Technology can capitalize on this trend by expanding its product offerings and entering new markets.
  • Investment in Emerging Markets: Lepu Medical Technology can explore untapped emerging markets where healthcare infrastructure and demand for medical devices are rapidly growing. This can help them diversify their revenue sources and reduce dependence on any single market.
  • Strategic Partnerships and Collaborations: Collaborating with other industry players, research institutes, and healthcare providers can open up avenues for Lepu Medical Technology to access new technologies, knowledge, and potential distribution networks.

Threats

In addition to opportunities, Lepu Medical Technology also faces certain threats that may pose challenges to its growth and overall performance. These threats include:

  • Regulatory Challenges: Compliance with various regulations, standards, and certifications in the healthcare industry can be complex and costly. Changes in government regulations or failure to meet compliance requirements can negatively impact Lepu Medical Technology's operations.
  • Intense Competition: The medical technology sector witnesses intense competition, with new entrants and established players constantly striving for market share. Lepu Medical Technology needs to continuously innovate and deliver superior products to stay ahead of the competition.
  • Technological Advancements: Rapid technological advancements in the industry bring both opportunities and threats. Lepu Medical Technology needs to keep pace with technological changes and ensure their products remain relevant and up-to-date.

Lepu Medical Technology Beijing Co valuation based on historical P/E ratio, EBIT, and P/S ratio.

Lepu Medical Technology Beijing Co shares outstanding

The number of shares was Lepu Medical Technology Beijing Co in 2023 — This indicates how many shares 1.862 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Lepu Medical Technology Beijing Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Lepu Medical Technology Beijing Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Lepu Medical Technology Beijing Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Lepu Medical Technology Beijing Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Lepu Medical Technology Beijing Co Stock splits

In Lepu Medical Technology Beijing Co's history, there have been no stock splits.

Lepu Medical Technology Beijing Co Stock Dividend

In 2023, Lepu Medical Technology Beijing Co paid a dividend amounting to 0.34 CNY. Dividend means that Lepu Medical Technology Beijing Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Lepu Medical Technology Beijing Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Lepu Medical Technology Beijing Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Lepu Medical Technology Beijing Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Lepu Medical Technology Beijing Co Dividend History

DateLepu Medical Technology Beijing Co Dividend
2026e0.38 undefined
2025e0.38 undefined
2024e0.38 undefined
20230.34 undefined
20220.28 undefined
20210.23 undefined
20200.2 undefined
20190.17 undefined
20180.13 undefined
20170.1 undefined
20160.08 undefined
20150.07 undefined
20140.07 undefined
20130.09 undefined
20120.09 undefined
20110.13 undefined
20100.06 undefined

Lepu Medical Technology Beijing Co Stock Payout Ratio

In 2023, Lepu Medical Technology Beijing Co had a payout ratio of 22.15%. The payout ratio indicates the percentage of the company's profits that Lepu Medical Technology Beijing Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Lepu Medical Technology Beijing Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Lepu Medical Technology Beijing Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Lepu Medical Technology Beijing Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Lepu Medical Technology Beijing Co Payout Ratio History

DateLepu Medical Technology Beijing Co Payout ratio
2026e22.56 %
2025e22.59 %
2024e22.94 %
202322.15 %
202222.68 %
202123.97 %
202019.8 %
201916.84 %
201818.68 %
201719.6 %
201620.51 %
201521.88 %
201425 %
201340.91 %
201236 %
201143.1 %
201025 %
200922.15 %
200822.15 %
200722.15 %
200622.15 %
Unfortunately, there are currently no price targets and forecasts available for Lepu Medical Technology Beijing Co.

Lepu Medical Technology Beijing Co Earnings Surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20240.27 0.26  (-5.02 %)2024 Q1
12/31/20230.21 -0.05  (-124.39 %)2023 Q4
9/30/20230.37 0.21  (-43.81 %)2023 Q3
6/30/20230.4 0.2  (-51 %)2023 Q2
3/31/20230.29 0.32  (8.57 %)2023 Q1
12/31/20220.17 0.21  (19.17 %)2022 Q4
9/30/20220.29 0.3  (3.11 %)2022 Q3
6/30/20220.53 0.4  (-23.68 %)2022 Q2
9/30/20210.29 0.11  (-62.95 %)2021 Q3
6/30/20210.32 0.55  (70.23 %)2021 Q2
1
2
3
4

Eulerpool ESG Scorecard© for the Lepu Medical Technology Beijing Co stock

Eulerpool World ESG Rating (EESG©)

49/ 100

🌱 Environment

46

👫 Social

34

🏛️ Governance

68

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
3,975.24
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees50.5
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

Kontaktformular an uns. The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Lepu Medical Technology Beijing Co Stock Shareholders

%
Name
Stocks
Change
Date
7.78 % WP Medical Technologies, Inc.123,968,60009/30/2023
4.25 % Beijing Dehou Yimin Investment Management Co., Ltd.67,750,00009/30/2023
2.95 % Zhong Ou Asset Management Co., Ltd.46,992,5914,889,8609/30/2023
2.55 % Hwabao WP Fund Management Co., Ltd.40,582,9256,947,9069/30/2023
2.31 % Hongde Fund Management Co., Ltd.36,813,620-2,237,33212/31/2023
2.25 % Ningbo Houde Yimin Investment Management Co., Ltd.35,850,00009/30/2023
15.32 % China Shipbuilding Industry Corporation No.725 Institute244,063,78809/30/2023
14.32 % Pu (Zhong Jie)228,074,74909/30/2023
1.10 % E Fund Management Co. Ltd.17,550,7492,039,6009/30/2023
0.98 % Norges Bank Investment Management (NBIM)15,647,7734,941,90212/31/2023
1
2
3
4
5
...
10

Lepu Medical Technology Beijing Co Executives and Management Board

Mr. Zhibin Zhang47
Lepu Medical Technology Beijing Co General Manager
Compensation 2.1 M
Ms. Yong Wang50
Lepu Medical Technology Beijing Co Chief Financial Officer, Senior Deputy General Manager
Compensation 1.8 M
Mr. Zhanjiang Wei51
Lepu Medical Technology Beijing Co Senior Deputy General Manager
Compensation 1.8 M
Mr. Bingfeng Zhang43
Lepu Medical Technology Beijing Co Deputy General Manager
Compensation 1.6 M
Ms. Weina Jiang44
Lepu Medical Technology Beijing Co Secretary of the Board
Compensation 1.5 M
1
2
3

Lepu Medical Technology Beijing Co stock: Frequently Asked Questions

What values and corporate philosophy does Lepu Medical Technology Beijing Co represent?

Lepu Medical Technology Beijing Co Ltd represents values of innovation, quality, and customer-centricity. With a strong corporate philosophy focused on enhancing human well-being, Lepu Medical is committed to providing advanced medical devices and solutions. The company upholds integrity and accountability while striving for excellence in research, development, and manufacturing. Lepu Medical takes pride in its commitment to meeting the evolving healthcare demands and aims to contribute to the global medical community through continuous improvement and cutting-edge technologies. As a leading player in the medical industry, Lepu Medical Technology Beijing Co Ltd consistently prioritizes patient welfare and ultimately aims to improve healthcare outcomes worldwide.

In which countries and regions is Lepu Medical Technology Beijing Co primarily present?

Lepu Medical Technology Beijing Co Ltd primarily operates in several countries and regions worldwide. Their presence can be largely found in China, where the company is based and headquartered. Additionally, Lepu Medical Technology has expanded its operations to other Asian countries, including India and Southeast Asian nations like Indonesia, Malaysia, and Thailand. Furthermore, Lepu Medical Technology has established a significant presence in Europe, particularly in Germany and Italy. The company also has a growing presence in the United States, where it aims to tap into the vast healthcare market.

What significant milestones has the company Lepu Medical Technology Beijing Co achieved?

Lepu Medical Technology Beijing Co Ltd has achieved several significant milestones. It has emerged as a leading medical device manufacturer in China, specializing in cardiovascular and endovascular products. The company has successfully developed innovative technologies, such as drug-eluting stents and bioresorbable vascular scaffolds, which have revolutionized cardiovascular treatments. Lepu Medical Technology Beijing Co Ltd has also established a strong global presence through strategic partnerships and distribution channels, ensuring the widespread availability of its high-quality medical devices. With a commitment to research and development, the company continues to drive advancements in the field of medical technology, enhancing patient outcomes worldwide.

What is the history and background of the company Lepu Medical Technology Beijing Co?

Lepu Medical Technology Beijing Co Ltd is a leading medical device company based in China. It was founded in 1999 and has since grown to become a global player in the healthcare industry. Lepu Medical specializes in the research, development, manufacturing, and distribution of innovative medical devices and solutions. The company is dedicated to improving patient care by offering high-quality and cost-effective products across various medical fields such as cardiovascular, interventional, and surgical treatment. With a strong emphasis on research and development, Lepu Medical has garnered a solid reputation for its cutting-edge technologies and product portfolio.

Who are the main competitors of Lepu Medical Technology Beijing Co in the market?

The main competitors of Lepu Medical Technology Beijing Co Ltd in the market include leading medical technology companies such as Medtronic, Boston Scientific, Edwards Lifesciences, and Abbott Laboratories. These companies also specialize in the development and manufacturing of medical devices and healthcare solutions. Lepu Medical Technology competes with these industry leaders by offering innovative products and solutions, maintaining a strong market presence, and continuously investing in research and development.

In which industries is Lepu Medical Technology Beijing Co primarily active?

Lepu Medical Technology Beijing Co Ltd is primarily active in the healthcare industry.

What is the business model of Lepu Medical Technology Beijing Co?

Lepu Medical Technology Beijing Co Ltd operates under the business model of designing, developing, manufacturing, and distributing medical devices and equipment. The company specializes in the fields of interventional cardiology, vascular surgery, and cardiac surgery. Lepu Medical focuses on providing innovative and high-quality products to improve patient outcomes and enhance medical professionals' efficacy. By constantly investing in research and development, the company stays at the forefront of medical technology advancements. Lepu Medical's commitment to advancing healthcare solutions and its wide range of offerings make it a leading player in the industry.

What is the P/E ratio of Lepu Medical Technology Beijing Co 2024?

The Lepu Medical Technology Beijing Co P/E ratio is 14.44.

What is the P/S ratio of Lepu Medical Technology Beijing Co 2024?

The Lepu Medical Technology Beijing Co P/S ratio is 2.77.

What is the AlleAktien quality score of Lepu Medical Technology Beijing Co?

The AlleAktien quality score for Lepu Medical Technology Beijing Co is 6/10.

What is the revenue of Lepu Medical Technology Beijing Co 2024?

The expected Lepu Medical Technology Beijing Co revenue is 9.02 B CNY.

How high is the profit of Lepu Medical Technology Beijing Co 2024?

The expected Lepu Medical Technology Beijing Co profit is 1.73 B CNY.

What is the business model of Lepu Medical Technology Beijing Co

Lepu Medical Technology Beijing Co Ltd is a Chinese company that offers medical devices and medical solutions. The company provides products and services in the cardiology, surgery, intensive care, and gynecology divisions, which contribute to improving medical patient care.

What is the Lepu Medical Technology Beijing Co dividend?

Lepu Medical Technology Beijing Co pays a dividend of 0.28 CNY distributed over payouts per year.

How often does Lepu Medical Technology Beijing Co pay dividends?

The dividend cannot currently be calculated for Lepu Medical Technology Beijing Co or the company does not pay out a dividend.

What is the Lepu Medical Technology Beijing Co ISIN?

The ISIN of Lepu Medical Technology Beijing Co is CNE100000H44.

What is the Lepu Medical Technology Beijing Co ticker?

The ticker of Lepu Medical Technology Beijing Co is 300003.SZ.

How much dividend does Lepu Medical Technology Beijing Co pay?

Over the past 12 months, Lepu Medical Technology Beijing Co paid a dividend of 0.34 CNY . This corresponds to a dividend yield of about 2.54 %. For the coming 12 months, Lepu Medical Technology Beijing Co is expected to pay a dividend of 0.38 CNY.

What is the dividend yield of Lepu Medical Technology Beijing Co?

The current dividend yield of Lepu Medical Technology Beijing Co is 2.54 %.

When does Lepu Medical Technology Beijing Co pay dividends?

Lepu Medical Technology Beijing Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Lepu Medical Technology Beijing Co?

Lepu Medical Technology Beijing Co paid dividends every year for the past 17 years.

What is the dividend of Lepu Medical Technology Beijing Co?

For the upcoming 12 months, dividends amounting to 0.38 CNY are expected. This corresponds to a dividend yield of 2.89 %.

In which sector is Lepu Medical Technology Beijing Co located?

Lepu Medical Technology Beijing Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lepu Medical Technology Beijing Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lepu Medical Technology Beijing Co from 6/30/2023 amounting to 0.341 CNY, you needed to have the stock in your portfolio before the ex-date on 6/30/2023.

When did Lepu Medical Technology Beijing Co pay the last dividend?

The last dividend was paid out on 6/30/2023.

What was the dividend of Lepu Medical Technology Beijing Co in the year 2023?

In the year 2023, Lepu Medical Technology Beijing Co distributed 0.275 CNY as dividends.

In which currency does Lepu Medical Technology Beijing Co pay out the dividend?

The dividends of Lepu Medical Technology Beijing Co are distributed in CNY.

Other fundamentals and analyses of Lepu Medical Technology Beijing Co in the deep dive.

Our stock analysis for Lepu Medical Technology Beijing Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lepu Medical Technology Beijing Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.